Singapore, April 8 -- US-based RoosterBio, Inc., a leading supplier of human mesenchymal stem/stromal cells (hMSCs), highly engineered bioprocess media, and advanced therapy manufacturing solutions for hMSCs and exosomes, has announced an exclusive distributor partnership with MineBio Life Sciences, a trusted partner to China's biopharmaceutical and advanced therapy community.

Under the agreement, MineBio will distribute RoosterBio's full platform of research-grade and CliniControl™ cGMP-grade MSC and exosome bioprocessing media throughout China. Critically, MineBio has already secured import approval for RoosterBio's research use only and cGMP CliniControl™ MSC and exosome bioprocessing media platform, enabling orders to be ...